It has been shown that 65–85% of RA patients carry at least one MHC class II risk allele (i.e., SE+) [4–7], as opposed to protective alleles (SE-), such as HLA-DRB1*04:02 [3, 8]. The gene discussed is HLA-DRB1; the disease is rheumatoid arthritis.